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Abstract
Background: Congenital chloride diarrhea (CLD; OMIM 214700) is a rare autosomal recessive disorder caused by
pathogenic variations in the solute carrier family 26 member A3 (SLC26A3) gene. Without salt substitution, this
chronic diarrheal disorder causes severe dehydration and electrolyte disturbances. Homozygous variants in the
nearby gene SLC26A4 disrupt anion exchange in the inner ear and the thyroid, causing Pendred syndrome (PDS;
OMIM 274600), which is the most frequent form of syndromic deafness.
Case presentation: We report an unusual co-occurrence of two rare homozygous mutations in both the SLC26A3
and SLC26A4 genes, causing a rare combination of both CLD and PDS in two siblings. Although the clinical pictures
were typical, the combined loss of these anion transporters might modulate the risk of renal injury associated with
CLD.
Conclusions: Familial presentation of two rare autosomal recessive disorders with loss of function of different
SLC26 anion transporters is described. Independent homozygous variants in the SLC26A3 and SLC26A4 genes cause
CLD and PDS in siblings, shedding light on co-occurrence of rare recessive traits in the progeny of consanguineous
couples.
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Background
Congenital chloride diarrhea (CLD; OMIM 214700) is a
rare autosomal recessive disorder. It is caused by patho-
genic variations in the solute carrier family 26 member
A3 (SLC26A3) gene on chromosome 7q31, which en-
codes for an apical epithelial chloride-bicarbonate ex-
changer of the terminal ileum and large intestine [1].
Homozygous mutations in the nearby gene SLC26A4
disrupt anion exchange in the inner ear and the thyroid,
causing the recessive Pendred syndrome (OMIM
274600) [2, 3].
Sporadic cases of SLC26A3-related CLD have been re-
ported worldwide, but founder mutations are associated
with higher incidences in Finland (1:30,000 to 1:40,000),
Poland (1:200,000) and in the Arab Middle East (1:
3200–1:5000) [4]. CLD is characterized by watery diar-
rhea with high levels of chloride (> 90mmol/l) and low
pH, leading to hypochloremia, hypokalemia, metabolic
alkalosis and dehydration. During pregnancy, fetal CLD
is associated with polyhydramnios and dilated intestinal
loops resembling ultrasonic signs of intestinal obstruc-
tion [5, 6]. CLD newborns are often slightly premature
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and have distended abdomens and watery diarrhea. Al-
though untreated dehydration and electrolyte imbalance
are life-threatening, salt replacement with NaCl and KCl
solutions allows favorable long-term outcome in patients
with CLD [6]. CLD might be complicated by renal in-
jury, intestinal inflammation and male subfertility [7].
SLC26A4-related Pendred syndrome (PDS) is charac-
terized by hearing loss, starting in late childhood or early
adulthood, and goiter with hypothyroidism [8]. The se-
verity and progress of congenital sensory (cochlear)
hearing loss varies and the inner ear may be malformed
to different degrees. If this malformation involves both
the cochlea and the vestibular organ, PDS is associated
with vestibular areflexia with late motor milestones, de-
layed walking age, and balance problems. A characteris-
tic feature of PDS is enlarged vestibular aqueducts [3].
Although PDS is one of the most frequent forms of syn-
dromic deafness, with the estimated incidence of 1–9:
100,000 worldwide [8], it has no distinct founder popula-
tions as seen for the SLC26A3-associated CLD.
While pathogenic SLC26 variants are rare and cases
mostly solitary, we report an unusual co-occurrence of
two rare homozygous mutations in both the SLC26A3
and SLC26A4 genes, causing a rare combination of both
CLD and PDS in two siblings. This finding uncovers the
clinical challenges and genetic risk associated with reces-
sive traits in the progeny of consanguineous families.
Case presentation
The parents were healthy first cousins from Lebanon,
currently living in Sweden. Furthermore, the parents of
the mother were also first cousins. Family history in-
volved no hearing disorders or gastrointestinal diseases.
The mother had a history of five pregnancies and four
deliveries. The first child was stillborn; a healthy boy was
born 1 year thereafter, and the affected boy 1 year later.
Three years later, the fourth pregnancy was complicated
by an early miscarriage, and 1 year thereafter, the af-
fected girl was born.
The affected boy
Pregnancy ultrasound at gestational week 29 displayed
polyhydramnios and dilated intestinal loops in the fetus,
resulting in a suspicion of atresia. The boy was born at
36 weeks with a birth weight of 3075 g. He had a dis-
tended abdomen, but normal findings in colon radiology
and small-bowel passage excluded intestinal atresia. Oral
nutrition was started but the baby lost weight, the abdo-
men became more distended, and diarrhea was misinter-
preted as urine. The boy deteriorated and developed
hypokalemic metabolic alkalosis. Three weeks after the
birth, a loop ileostomy was performed and a dilated in-
testine with poor peristalsis was noted. Four weeks later,
a second operation was performed for a prolapse of the
stoma, and two months after the birth, the stoma was
removed due to a severe prolapse. Three days after the
operation, a thrombosis in the brachiocephalic vein and
the superior vena cava was detected and treated with
dalteparin. Intestinal biopsies revealed normal histology,
and metabolic tests as well as tests for cystic fibrosis
were normal. Serum levels of electrolytes, bicarbonate
and pH were normal when parenteral nutrition was
given, but as soon as oral feeding was started, hypo-
chloremic and hypokalemic metabolic alkalosis ap-
peared. Two months after the birth, a suspicion of CLD
was raised and confirmed by measuring high fecal chlor-
ide. Treatment with a solution of NaCl and KCl was
started orally according to the recommendations [6].
Blood tests became normal and the abdomen became
less distended but watery stools ten times a day or more
persisted. After years of follow-up, the boy, currently 12
years old, still passes 7–8 watery stools per day but has
normal growth and development without signs of hypo-
chloremia or metabolic alkalosis. Treatment with the so-
lution of NaCl and KCl is lifelong. Repeated tests for
renal function, ultrasounds of the kidneys, electrolyte
balance and thyroidal status have been normal.
The routine otoacoustic emission test (OAE) at birth
was normal, but at the age of 4, a bilateral moderate sen-
sory hearing impairment was diagnosed [a pure tone
average (PTA4, 0.5, 1, 2, 4 kHz), right ear 89 dBHL, left
ear 55 dBHL] using play audiometry. OAE was negative,
and tympanometry showed normal curves. The hearing
loss was suspected because of poor language acquisition
and because the younger sister had just been diagnosed
with the same condition. The hearing loss was progres-
sive in the right ear but remained stable in the left. The
boy received bilateral hearing aids and is now being con-
sidered for cochlear implants. Currently at the age of 12,
he is attending a special school for hard of hearing/deaf
children and communicates with spoken language as
well as with some sign language.
The affected girl
Pregnancy ultrasound at gestational week 25 showed a
distended bowel but no polyhydramnios. A baby girl was
born at 35 weeks with a birth weight of 2600 g. Her ab-
domen was slightly distended and the meconium watery.
After admission to the neonatal intensive care unit, oral
feeding was started, but the baby developed hypokal-
emia, hypochloremia, hyponatremia, and metabolic al-
kalosis, similar to her older brother. High fecal chloride
confirmed the diagnosis of CLD. Six days after the birth,
salt replacement therapy was started according to the
recommendations [6]. Blood tests normalized and the
baby became livelier, but she continued to pass loose
stools. She was discharged from hospital 2 weeks after
the birth. At the current age of 8 years, she passes 7–8
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watery stools per day but shows normal growth and de-
velopment. As for her brother, the treatment with salt
solution is lifelong. Repeated tests for renal function, ul-
trasounds of the kidneys, electrolyte balance and thyroi-
dal status have been normal.
The girl failed the otoacoustic emission test (OAE) at
7 days and again at 12 days. At the age of 6 weeks, brain-
stem response audiometry revealed a bilateral moderate
to severe sensory hearing impairment (right ear 50
dBHL, left ear 50 dBHL). Bilateral hearing aids were fit-
ted. The hearing loss was progressive, and at the age of
5 years, she received a cochlear implantation (CI) on the
right ear. The pre-operative radiological examinations
(CT and MRI) revealed minor malformations of the co-
chleas, and the semicircular canals were normal. The in-
ternal auditory canals were wide and the vestibular
aqueducts were enlarged (EVA). At the time of the oper-
ation, the so-called “gusher” (increased perilymphatic
pressure) appeared as a characteristic of Pendred syn-
drome. CI in the right ear and a hearing aid on the left
resulted in significantly improved language acquisition
and speech. The girl currently attends a special pre-
school for hard of hearing/deaf children and learns both
Swedish spoken language and sign language.
Genetic diagnoses
Genetic testing for CLD was performed at our research
laboratory (Department of Medical Genetics, University
of Helsinki, Finland) when the boy was 1 year old.
SLC26A3 exons were amplified using intronic primers as
described [9]. The Arab founder mutation c.559G > T
(p.G187X) on intron 5 [1] was excluded and no other
exons or exon-intron boundaries showed pathogenic
variations. However, PCR amplification of exon 1 was
unsuccessful from the patient sample.
The suspected deletion around the non-coding exon
1 was further mapped by multiple PCR and sequen-
cing reactions on both the patient sample and the
parental samples. All PCR reactions were run in a
volume of 25 μL involving 1 x PCR buffer, 1.5 mM
MgCl2, 200 μM of each dNTPs, 0.8 μM of each pri-
mer, 0.03 U/μL of Hot Star Taq Plus DNA polymer-
ase (Qiagen, Valencia, CA), and 10 ng of genomic
DNA. Cycling conditions were 95 °C for 5 min,
followed by 30 cycles of 95 °C for 30 s, 57 °C for 30 s,
and 72 °C for 45 s, and by the final extension of 72 °C
for 10 min. The PCR products were studied on 2%
agarose gels. ExoSAP-IT PCR clean-up was performed
according to manufacturer’s instructions (Thermo
Fisher Scientific) and PCR products were further
studied by direct sequencing into both directions util-
izing the BigDye Terminator v.3.1 Cycle Sequencing
Kit and the ABI3730xl DNA Analyzer (Thermo Fisher
Scientific).
We designed primers to amplify flanking sequences
around 16 single nucleotide polymorphisms (SNPs) from
54 kilobases upstream (rs10274491) to 5 kb downstream
(rs4730264) from the exon 1 of the SLC26A3 gene. We
identified regions in which PCR was unsuccessful in the
patient sample but successful in the parental samples.
This approach allowed localization of the approximate
borders of the deletion, which was further characterized
using specific primers (5′-CCGTGTTCAAGGACAATG
TG-3′ in intron 1 and 5′-TGAGCCAGTCAGTGCAAA
AC-3′ in the promoter). The deletion involved 8596 nu-
cleotides from 4.3 kilobases upstream of exon 1 to 4.2
kilobases downstream of it. This homozygous deletion
found in the patient sample, and present in a heterozy-
gous form in the parental samples, results in a deletion
of a large segment including the intestinal promoter for
transcription and the non-coding exon 1 of the SLC26A3
gene [10]. Taking into account the typical clinical pic-
ture of CLD in the patient, this large deletion was impli-
cated as the causative variation for CLD. When the
sister was born, no further genetic test for SLC26A3 was
done because the clinical diagnosis of CLD – both the
clinical picture and high fecal chloride – were consistent
with the disease.
When hearing impairment was clinically diagnosed,
both the boy and the girl had additional genetic testing
(Department of Clinical Genetics/Rigshospitalet,
Copenhagen, Denmark) and were found to be homozy-
gous for the SLC26A4 change c.384delT (p.Phe128-
Leufs#17). The parents were heterozygous carriers for
this pathogenic variant. This deletion is previously unre-
ported and not found in genetic databases but lies at the
location where one pathogenic variant c.382_384delTT-
TinsAA (p.Phe128Lysfs) has been reported in a single
individual [11].
The region covering SLC26A3 and SLC26A4 genes, in-
cluding their promoters, is shown in Fig. 1. These genes
are located in opposite strands on 7q22.3-q31.1 and the
SLC26A3 deletion found in the patient does not cover
any enhancer elements of the gene. Thereby, the co-
occurrence of these diseases is apparently not affected
by any enhancers, further supporting the causative role
of the two rare and independent mutations for CLD and
PDS in these patients.
Discussion and conclusions
The described co-occurrence of two rare recessive
pathogenic variants independent of each other is highly
unusual and previously unreported for the members of
the SLC26 gene family. As for CLD, founder populations
in Finland, Poland and the Arab Middle East account for
the majority of the affected individuals [1]. The affected
siblings described here are, however, homozygous for a
large deletion which is solitary but enriched in the
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progeny for consanguinity in the family. No other such
large deletions have been described in association with
CLD [1]. As this deletion of 8.6 kb is still distantly lo-
cated (50 kb) from the SLC26A4 gene and not covering
any enhancer elements of the genes (Fig. 1), the rare
SLC26A4 nonsense change is most likely independently
causative for PDS in these patients. These cases highlight
the importance of consanguineous family history in diag-
nostics of rare childhood disorders.
The clinical picture of CLD in these patients was typ-
ical as such, and the age at the diagnosis of the older
child in the family was close to the mean of 2.7 months
reported in the literature [7]. While evident genotype-
phenotype correlation in CLD remains non-existent and
functional studies of different SLC26A3 disease muta-
tions have revealed consistent loss of function [12], dif-
ferential clinical presentation in these siblings supports
earlier conclusions that modifier genes may affect the
clinical picture of CLD [13]. This is supported by the
differential severity of diarrhea in these siblings in the
infancy. Additionally, the younger child showed fewer
ultrasonic features of CLD while in utero, although the
characteristics of CLD include intrauterine onset of
watery diarrhea, polyhydramnios, and dilated intestinal
loops in the fetus [5]. Notably, unnecessary operations
before the diagnosis of CLD in the older sibling may
have modulated his diarrheal symptoms. The deep ven-
ous thrombosis in the boy might be associated with se-
vere dehydration, as no thromboembolic complications
have arisen in larger series of CLD [7]. Because chronic
dehydration reduces the volume of diarrhea, diagnostics
of CLD is challenging and often leads to suspicion of in-
testinal obstruction [7]. However, once the disorder is
suspected, the diagnosis is easily made by measuring
fecal chloride [6], as also described here. Salt
replacement therapy allows normal growth and develop-
ment in a patient with CLD [7], as seen in both the sib-
lings described here.
Both the boy and the girl showed a typical pattern of
hearing loss attributed to Pendred syndrome. This hear-
ing loss is often progressive and, in many cases, pro-
found in young adulthood [3]. The radiological findings
of enlarged vestibular aqueduct (EVA) and an enlarged
meatus acusticus internus is typical for PDS, as is the
gusher found during the girl’s operation when opening
the round window. These siblings have not so far shown
signs of hypothyroidism, which may be absent in cases
with late-onset PDS [14].
SLC26 anion transporters show a highly differential
tissue distribution [12]. SLC26A3 is mostly expressed by
the apical intestinal epithelium and the male reproduct-
ive tract [15], while SLC26A4 shows expression in the
inner ear and the thyrocyte [16]. Although loss of func-
tion of these two SLC26 anion transporters is unlikely to
have any additive effects, their possible consequences are
related to kidney function. Pendrin shows expression on
the apical membrane of the renal collecting duct interca-
lated cell [17]. While loss of SLC26A4 alone is compen-
sated with other transporters in the nephron, and
neither Pendred patients nor SLC26A4-deficient mice
develop overt acid-base disturbances [18], SLC26A4 in
the kidneys is regulated by systemic chloride load and
acid-base status [19]. Furthermore, untreated CLD is as-
sociated with hypochloremic and hypokalemic metabolic
alkalosis and a risk for renal calcifications and chronic
kidney disease [20]. Therefore, the life-long chloride-
losing diarrhea of CLD together with the loss of function
of renal SLC26A4-mediated transport might modulate
the risk of kidney disease in these siblings. Their co-
occurrence of CLD and PDS thereby underlines the
Fig. 1 SLC26A3 (purple arrow) and SLC26A4 (green arrow) genes on chromosome 7q22.3-q31.1 (marked with red bar) are shown. The promoters
of these genes are marked with arrows and the SLC26A3 deletion causative for CLD with a red square bracket. The two nearest enhancer
elements are shown, of which one is 17.8 kb upstream of SLC26A3; none is near SLC26A4. The 8.6 kb deletion responsible for CLD extends
upstream only about half-way to the nearest enhancer element. The image is a screen capture from the FANTOM5
database (http://fantom.gsc.riken.jp/zenbu)
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importance of salt replacement therapy and maintenance
of normal acid-base and electrolyte balance.
This study describes an unusual presentation of two
unique recessive diseases caused by homozygous
changes in two nearby genes, SLC26A3 and SLC26A4.
The clinical picture in the siblings highlights the chal-
lenges in diagnostics of rare disorders in children of con-
sanguineous couples.
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